Related Experiment Video
Updated: Aug 7, 2026

Visualization of DNA Repair Proteins Interaction by Immunofluorescence
Published on: June 26, 2020
DNA damage by antitumor acridines mediated by mammalian DNA topoisomerase II
Abstract:
Antitumor drugs from many chemical classes have been shown to induce protein-linked DNA breaks in cultured mammalian cells and in vitro in the presence of purified mammalian DNA topoisomerase II. The possibility that mammalian DNA topoisomerase II is an intracellular target which mediates drug-induced DNA breaks is supported by the following studies using 4'-(9-acridinylamino)methane-sulfon-m-anisidide (m-AMSA): (a) a single m-AMSA-dependent DNA cleavage activity copurified with calf thymus DNA topoisomerase II activity at all chromatographic steps of the enzyme purification; (b) m-AMSA-induced DNA cleavage by this purified activity resulted in the covalent attachment of protein to the 5'-ends of the DNA via a tyrosyl phosphate bond. This covalently linked protein has the same reduced molecular weight as purified calf thymus DNA topoisomerase II. The possibility that topoisomerase II-mediated DNA breaks may be responsible for cytotoxicity has also been investigated using a number of m-AMSA-related acridines. The level of topoisomerase II-mediated DNA breaks in vitro strongly correlates with the level of protein-linked DNA breaks in cultured cells and drug-induced cytotoxicity. These results suggest that mammalian DNA topoisomerase II may be a cytotoxic target of antitumor acridines.
Insights
Antitumor drugs cause DNA breaks by targeting mammalian DNA topoisomerase II. This enzyme mediates drug-induced DNA damage and cytotoxicity, suggesting it
Area of Science:
- Molecular Biology
- Cancer Research
- Biochemistry
Background:
- Antitumor drugs from various chemical classes induce protein-linked DNA breaks in mammalian cells and in vitro.
- Mammalian DNA topoisomerase II is a potential intracellular target mediating these drug-induced DNA breaks.
Purpose of the Study:
- To investigate if mammalian DNA topoisomerase II is an intracellular target for antitumor drugs.
- To explore the role of topoisomerase II-mediated DNA breaks in drug-induced cytotoxicity.
Main Methods:
- Purification of calf thymus DNA topoisomerase II.
- Assaying m-AMSA-dependent DNA cleavage activity.
- Analyzing protein-DNA covalent attachment via tyrosyl phosphate bonds.
- Correlating in vitro DNA breaks with cellular DNA breaks and cytotoxicity using m-AMSA-related acridines.
Main Results:
- A single m-AMSA-dependent DNA cleavage activity copurified with DNA topoisomerase II.
- m-AMSA induced DNA cleavage resulted in covalent protein attachment to DNA 5'-ends.
- The covalently linked protein matched the molecular weight of purified DNA topoisomerase II.
- In vitro topoisomerase II-mediated DNA breaks strongly correlated with cellular DNA breaks and cytotoxicity.
Conclusions:
- Mammalian DNA topoisomerase II is a likely intracellular target for antitumor drugs.
- Topoisomerase II-mediated DNA breaks are implicated in the cytotoxic effects of antitumor acridines.
Related Concept Videos
Nucleotide Excision Repair
DNA Topoisomerases
Types and Mechanism of action
Topoisomerases are divided into two main types. Type I...
DNA Damage can Stall the Cell Cycle
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
DNA Damage Can Stall the Cell Cycle
Inhibitors of Bacterial DNA Synthesis

